Evidence map›Paper›PMID 36303547›Full record

ArticleFrontiers in genetics2022

Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway.

Yuanjun Hu, Sihan Zhu, Rizhen Xu, Manxia Wang, Furong Chen, Zeshun Zhang, Binghong Feng, Jian Wang, Zhongping Chen, Jing Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Roles and regulation of δ-catenin in tumorigenesis and neuronal diseases.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yuanjun HuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Sihan ZhuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Rizhen XuDepartment of Surgery, Guangzhou University of Chinese Medicine, Guangzhou, China.
Manxia WangDepartment of Pharmacology, Guangdong Pharmaceutical University, Guangzhou, China.
Furong ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Zeshun ZhangDepartment of Surgery, Guangzhou University of Chinese Medicine, Guangzhou, China.
Binghong FengDepartment of Pharmacology, Guangdong Pharmaceutical University, Guangzhou, China.
Jian WangDepartment of Neurosurgery/Neuro-Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhongping ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Jing WangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Sun Yat-sen University Cancer Center · CNGuangdong Pharmaceutical University · CNGuangzhou University of Chinese Medicine · CNSun Yat-sen University · CNState Key Laboratory of Oncology in South China

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

delta-cateninEMTinvasionmedulloblastomaprognosis

Identifiers

PMID36303547
PMCPMC9595215
OpenAlexW4304608492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.